Form 4 Tracker
CYTOKINETICS INC
CYTK

46 insider filings · Latest: Jun 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 17, 2026Mar 18 5:46 PMSung LeeEVP, Chief Financial Officer
Sale
4,935$62.15$306.7K87,127(D)

View →

Mar 17, 2026Mar 18 5:43 PMAndrew CallosEVP, Chief Commercial Officer
Sale
8,542$62.15$530.9K71,573(D)

View →

Mar 17, 2026Mar 18 5:40 PMFady Ibraham MalikEVP Research & Development
Sale
12,033$62.15$747.9K153,902(D)

View →

Mar 17, 2026Mar 18 5:37 PMRobert I BlumDirector, President & CEO
Sale
36,601$62.15$2.3M430,330(D)

View →

Mar 18, 2026Mar 18 4:55 PMAndrew CallosEVP, Chief Commercial Officer
Sale
1,930$62.07$119.8K78,185(D)

View →

Mar 16, 2026Mar 16 5:14 PMAndrew CallosEVP, Chief Commercial Officer
Sale
1,709$61.03$104.3K46,149(D)

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 1, 2026Jun 1 6:51 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
15,000$23.2639,000(D)

View →

May 27, 2026May 27 7:16 PMMuna BhanjiDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 7:14 PMJames M DalyDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 7:13 PMRobert Arthur HarringtonDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 7:12 PMJohn T HendersonDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 7:11 PMEdward M. Kaye MDDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 7:10 PMLynne B ParshallDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 7:09 PMRobert E LandryDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 7:08 PMWendell WierengaDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 7:07 PMNancy WysenskiDirector
Grant/Award
4,301$77.154,301(D)

View →

May 19, 2026May 20 4:00 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8047,886(D)

View →

May 5, 2026May 5 5:35 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8051,386(D)

View →

May 5, 2026May 5 4:20 PMWendell WierengaDirector
Option Exercise
4,032$12.400(D)

View →

May 5, 2026May 5 4:15 PMJohn T HendersonDirector
Option Exercise
20,000$7.610(D)

View →

May 5, 2026May 5 4:11 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
11,333$39.1313,070(D)

View →

May 1, 2026May 4 4:01 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
15,857$37.630(D)

View →

Apr 30, 2026Apr 30 4:22 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
15,000$23.2654,000(D)

View →

Apr 21, 2026Apr 21 4:22 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8054,886(D)

View →

Apr 7, 2026Apr 8 4:18 PMFady Ibraham MalikEVP Research & Development
Option Exercise
4,500$10.600(D)

View →

Mar 15, 2026Mar 17 4:11 PMRobert I BlumDirector, President & CEO
Grant/Award
113,529$60.06111,864(D)

View →

Page 1 of 2

Next →